Blog

Pharmacokinetic / dissolution claims save sustained release combination of naltrexone and bupropion from generic challenge.

September 30, 2019

Federal Circuit reversed district court decision to dismiss patent lawsuit at pleadings stage because dose adjustment required by claims was concrete application of natural law.

September 02, 2019

FDA clarifies requirements to be listed as the active ingredient in a drug product.

January 06, 2019

When will a preamble to a claimed method of treatment be given limiting effect? The answer might surprise you.

November 27, 2018

American patent rules seem to foreclose additional patent protection for new stereoisomers, while European patent rules offer some margin of hope.

June 24, 2018

Federal Circuit rules that eligibility for drug / diagnostic patent turns on distinction between manipulative steps and mental steps.

May 22, 2018

Patent claiming dose reduction for poor metabolizers affirmed at Federal Circuit.

April 22, 2018

Capital gains treatment is available only if the royalties are paid as consideration for all substantial rights to a patent.

April 03, 2018

Rejection of methyl homolog as prima facie obvious over old compound reversed under lead compound analysis.

February 27, 2018

Japanese patent laws allow applicants to extend patent protection an additional 18 months by following a simple filing sequence. 

February 05, 2018